Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus

Area of Science:

• Immunology
• Autoimmune Diseases
• Molecular Biology

Background:

• Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is crucial for T-cell regulation and preventing autoimmunity.
• Genetic studies link CTLA-4 to various autoimmune diseases.
• T cells in systemic lupus erythematosus (SLE) exhibit hyperactivity.

Purpose of the Study:

• To investigate the function of CTLA-4 in patients with systemic lupus erythematosus (SLE).
• To determine if CTLA-4 defects contribute to the hyperactive T-cell phenotype observed in SLE.

Main Methods:

• Compared CTLA-4 expression and function in T cells from SLE patients, other autoimmune diseases, and healthy controls.
• Assessed T-cell proliferation, lipid microdomain formation, and TCR-zeta phosphorylation after CD3/CD28 co-stimulation.
• Investigated CTLA-4 localization within lipid microdomains.

Main Results:

• Increased CTLA-4 expression was observed in SLE responder T cells compared to controls.
• CTLA-4 failed to regulate proliferation and signaling in SLE T cells.
• SLE T cells showed CTLA-4 exclusion from lipid microdomains, impairing its function.
• Normal CTLA-4 upregulation upon stimulation was absent in SLE T cells.

Conclusions:

• CTLA-4 dysfunction is identified as a potential driver of aberrant T-cell activation in SLE.
• The exclusion of CTLA-4 from lipid microdomains provides a mechanism for its loss of function.
• Targeting CTLA-4 dysfunction may offer a novel therapeutic strategy for SLE.